The HABP4 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human HeLa cell line, featuring targeted disruption of the HABP4 gene. This loss-of-function model enables systematic dissection of HABP4-mediated intracellular signaling and gene regulatory networks. The polyclonal nature preserves cellular heterogeneity, making it suitable for population-level studies of RNA-binding protein function and hyaluronan-dependent pathways without clonal bias. Researchers can utilize this tool to interrogate the roles of HABP4 in mRNA processing, stress granule dynamics, and p53 co-regulation.
HeLa cells, a widely used human cervical adenocarcinoma line, provide a robust and well-characterized epithelial model system. The host cell line is positive for human papillomavirus type 18 (HPV18), a feature that partially inactivates endogenous p53 through E6-mediated degradation, yet residual and p53-independent activities remain amenable to investigation. The parental HeLa background facilitates high transfection efficiency, rapid proliferation, and compatibility with diverse downstream assays. This context is particularly advantageous for investigating HABP4-dependent modulation of cell proliferation, apoptosis, and tumorigenic properties in a cervical cancer-relevant setting.
HABP4 encodes an intracellular hyaluronan-binding RNA-binding protein that physically interacts with CD44 and is phosphorylated by PKC, linking extracellular matrix cues to post-transcriptional gene regulation. It acts as a p53 co-regulator, directly modulating the transcription of critical target genes such as p21 and BAX, thereby influencing cell cycle arrest and apoptotic programs. Additionally, HABP4 forms complexes with PRMT1, RACK1, and heterogeneous nuclear ribonucleoproteins (e.g., hnRNP A2/B1) to orchestrate mRNA splicing, translation, and stress granule assembly. These interactions place HABP4 at the intersection of hyaluronan/CD44 signaling, PKC pathways, and p53-mediated tumor suppression.
In HeLa cells, where HPV18 E6 attenuates p53 function, HABP4 knockout offers a unique opportunity to decipher p53-cofactor dependencies and hyaluronan-driven signaling independent of viral interference. This model is specially suited for examining how HABP4 contributes to residual p53 activity or mediates p53-independent survival signaling in cervical adenocarcinoma. It also enables dissection of CD44-PKC-HABP4 conduits that might promote therapy resistance. By perturbing HABP4 in this context, investigators can explore compensatory mechanisms within the p53?Cp21?CBAX axis and assess alterations in RNA metabolism that underpin malignant phenotypes.
Typical experimental applications include western blotting and RT?qPCR analysis of p53 targets (p21, BAX) to validate pathway engagement, co-immunoprecipitation and RNA immunoprecipitation to map protein and mRNA interactions, immunofluorescence to monitor stress granule formation, apoptosis assays by flow cytometry, and p53 reporter assays to gauge transcriptional activity. Migration assays and drug resistance screens further expand the utility of these cells in cancer biology, hyaluronan signaling research, and RNA metabolism studies. For further information, please contact Ascent Research.
